LIC (Life Insurance Corporation of India), on 14 September, had divested a 2.011% stake in Sun Pharmaceutical Industries Ltd, taking its stake in the company...
On Wednesday, Dr. Reddy’s Laboratories Ltd pronounced the unveiling of Lenalidomide Capsules. It is a Therapeutic Equivalent Generic Version of Revlimid (lenalidomide) Capsules sanctioned by...
Dr. Reddy’s Laboratories (DRL), its fully owned step-down subsidiary Aurigene Pharmaceutical Services, not-for-profit R&D organisation Drugs for Neglected Diseases initiative and DNDi India Foundation have...
Dr Reddy’s lab said its subsidiary had signed an agreement with US-based Olema Pharmaceuticals Inc to research, develop and commercialise novel small molecule inhibitors of...
Ahmedabad-based Torrent Pharmaceuticals announced on May 27 that it had agreed with Dr Reddy’s lab to acquire four of its brands – “Styptovit-E”, “Finast”, “Finast-T”,...
EquityPandit’s Outlook for Dr. Reddy for the week (July 27,2020 – July 31, 2020) DR. REDDY: BSE: 500180| NSE: DRREDDY| ISIN: INE040A01026| SECTOR: PHARMA Stock closed...
EquityPandit’s Outlook for Dr. Reddy for the week (July 20,2020 – July 24, 2020) DR. REDDY: BSE: 500180| NSE: DRREDDY| ISIN: INE040A01026| SECTOR: PHARMA Stock closed...
EquityPandit’s Outlook for Dr. Reddy for the week (July 13,2020 – July 17, 2020) DR. REDDY: BSE: 500180| NSE: DRREDDY| ISIN: INE040A01026| SECTOR: PHARMA Stock closed...
EquityPandit’s Outlook for Dr. Reddy for the week (June 29, 2020 – July 03, 2020) DR. REDDY: BSE: 500180| NSE: DRREDDY| ISIN: INE040A01026| SECTOR: PHARMA Stock...
EquityPandit’s Outlook for Dr. Reddy for the week (June 22, 2020 – June 26, 2020) DR. REDDY: BSE: 500180| NSE: DRREDDY| ISIN: INE040A01026| SECTOR: PHARMA Stock...